HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Benzeneethanamine, alpha-methyl-, phosphate (1:1) → (S)-2'-(1H-imidazol-2-yl)-7'-(neopentyloxy)-5H-spiro[oxazole-4,9'-xanthen]-2-amine

HRID 335762
Print

Reaction equation

HRID 335762 reaction equation
[CH2:1]([O:6][C:7]1[CH:20]=[CH:19][C:18]2[O:17][C:16]3[C:11](=[CH:12][C:13](B4OC(C)(C)C(C)(C)O4)=[CH:14][CH:15]=3)[C@@:10]3([CH2:33][O:32][C:31]([NH2:34])=[N:30]3)[C:9]=2[CH:8]=1)[C:2]([CH3:5])([CH3:4])[CH3:3].Br[C:36]1[NH:37][CH:38]=[CH:39][N:40]=1.CC([O-])=O.[K+].CC(N)CC1C=CC=CC=1.OP(O)(O)=O>C(O)CCC.O.CO>[NH:37]1[CH:38]=[CH:39][N:40]=[C:36]1[C:13]1[CH:14]=[CH:15][C:16]2[O:17][C:18]3[C:9](=[CH:8][C:7]([O:6][CH2:1][C:2]([CH3:5])([CH3:4])[CH3:3])=[CH:20][CH:19]=3)[C@:10]3([CH2:33][O:32][C:31]([NH2:34])=[N:30]3)[C:11]=2[CH:12]=1
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

8

Reactant 4

HCID 62885Benzeneethanamine, alpha-methyl-, phosphate (1:1)HCID 517044Potassium AcetateHCID 27732612-Bromo-1H-imidazoleHCID 67246448(S)-2'-(neopentyloxy)-7'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-spiro[oxazole-4,9'-xanthen]-2-amine

Product 1

HCID 58466116(S)-2'-(1H-imidazol-2-yl)-7'-(neopentyloxy)-5H-spiro[oxazole-4,9'-xanthen]-2-amine

Reagents, catalysts & solvents 3

HCID 2631-ButanolSolventHCID 887MethanolSolventHCID 962WaterSolvent

Conditions

Temperature
120 °C

Procedure

A solution of (S)-2′-(neopentyloxy)-7′-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-spiro[oxazole-4,9′-xanthen]-2-amine (50 mg, 0.108 mmol) in BuOH (861 μL), 2-bromo-1H-imidazole (0.129 mmol), and KOAc (31.7 mg, 0.323 mmol) in Water (215 μL) was purged with Ar in a sealed tube. AmPhos (1.525 mg, 2.153 μmol) was added and the reaction was heated to 120° C. for 30 min in the microwave. The reaction was cooled to rt, diluted with MeOH (3 ml), loaded onto an AccuBOND II SCX cartridge, washed with MeOH (3 ml) and eluted with 2N NH3 in MeOH (6 ml) to give the crude product which was purified by reverse-phase preparative HPLC using a Gemini NX c!8 column (150*30 mm, 5 um), 0.1% TFA in CH3CN/H2O, gradient 0% to 70% over 10 min to provide (S)-2′-(1H-imidazol-2-yl)-7′-(neopentyloxy)-5H-spiro[oxazole-4,9′-xanthen]-2-amine.

Workup

  1. temperatureThe reaction was cooled to rt
  2. washwashed with MeOH (3 ml)
  3. washeluted with 2N NH3 in MeOH (6 ml)
  4. customto give the crude product which
  5. customwas purified by reverse-phase preparative HPLC
  6. customover 10 min

Sources & evidence

ORD record
ord-813580b86bc541abab42e4b658d2d333
Source dataset
uspto-grants-2014_11
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08883782B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes